Multicenter Observational Study of Myotonic Dystrophy Type 1

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

October 31, 2017

Conditions
Myotonic Dystrophy Type 1
Trial Locations (6)

14642

University of Rochester, Rochester

20892

NIH, Bethesda

43221

Ohio State University, Columbus

66160

University of Kansas Medical Center, Kansas City

94305

Stanford University, Stanford

100236

University of Florida, Gainesville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Florida

OTHER

collaborator

University of Kansas Medical Center

OTHER

collaborator

Ohio State University

OTHER

collaborator

Stanford University

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Biogen

INDUSTRY

collaborator

Muscular Dystrophy Association

OTHER

collaborator

Myotonic Dystrophy Foundation

OTHER

collaborator

The Marigold Foundation

UNKNOWN

lead

University of Rochester

OTHER

NCT02308657 - Multicenter Observational Study of Myotonic Dystrophy Type 1 | Biotech Hunter | Biotech Hunter